resiquimod has been researched along with gs-9620 in 2 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (gs-9620) | Trials (gs-9620) | Recent Studies (post-2010) (gs-9620) |
---|---|---|---|---|---|
465 | 14 | 318 | 46 | 9 | 46 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Enosi Tuipulotu, D; Lun, JH; Mackenzie, JM; Netzler, NE; White, PA | 1 |
2 other study(ies) available for resiquimod and gs-9620
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
Topics: Aminoquinolines; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Guanosine; Humans; Imidazoles; Imiquimod; Mice; Pteridines; RAW 264.7 Cells; Toll-Like Receptor 7; Virus Replication | 2018 |